ZYME Q2 2020 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+56.8% YoY

Gross Profit

-$27M-217.3% margin

Operating Income

-$40M-326.5% margin

Net Income

-$39M-315.2% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

+49.5%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$52M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$607M

Total Liabilities

$116M

Stockholders' Equity

$491M

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+56.8%
Gross Profit	-$27M	-$16M	-68.9%
Operating Income	-$40M	-$29M	-37.1%
Net Income	-$39M	-$29M	-34.0%

Revenue Segments

Up-front Technology Access Fee

$12M97%

Other Product

$359,0003%